Bovine cerebral ganglioside

Drug Profile

Bovine cerebral ganglioside

Alternative Names: Biosinax; Cronassial; E 0704; Ganglioside; Megan

Latest Information Update: 21 Feb 2002

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Fidia Farmaceutici
  • Class Gangliosides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Market Withdrawal Peripheral nervous system diseases
  • Discontinued Diabetic neuropathies

Most Recent Events

  • 21 Feb 2002 Discontinued-III for Diabetic neuropathies in USA (IM)
  • 21 Feb 2002 Discontinued-III for Peripheral nervous system diseases in Belgium (IM)
  • 21 Feb 2002 Discontinued-III for Peripheral nervous system diseases in Colombia (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top